Pancreatic Anatomy and Physiology — MCQs
CT scan of abdomen showing a structure branching within the liver. Identify the structure.
A 38-year-old female presents to the physician with complaints of excessive thirst and urination for the past 4 weeks. Her appetite has been normal and she has not had diarrhea. Blood chemistry showed mildly elevated glucose and glucagon. Physical examination reveals tenderness in the left upper quadrant and an erythematous necrotizing skin eruption on her legs. Radiographic studies show a tumor in the pancreas. Which of the following cells is responsible for this lesion?
The duct of Wirsung is:
A 45-year-old patient with chronic pancreatitis is suffering from malnutrition and weight loss secondary to inadequate pancreatic exocrine secretions. Which of the following is true regarding pancreatic secretions?
Which structure is located immediately posterior to the head of the pancreas?
Destruction of fat in acute pancreatitis is due to ?
Which of the following statements about the first part of the duodenum is false?
What is the median survival time for patients with carcinoma of the pancreas after surgery and adjuvant therapy?
After pancreaticoduodenectomy (PD surgery), when should the first postoperative follow-up visit be scheduled to assess the patient's recovery?
In acute pancreatitis, surgery is indicated in which one of the following conditions?
Pancreatic Anatomy and Physiology Indian Medical PG Practice Questions and MCQs
Question 1: CT scan of abdomen showing a structure branching within the liver. Identify the structure.
- A. Portal vein (Correct Answer)
- B. Superior vena cava
- C. Inferior vena cava
- D. Splenic vein
Explanation: ***Portal vein*** - The image shows a **branching vessel within the liver parenchyma**. The **portal vein** enters the liver at the porta hepatis and branches extensively to supply the liver with nutrient-rich, deoxygenated blood from the gastrointestinal tract. - On a CT scan, the portal vein and its branches appear as prominent, contrast-filled structures centrally located within the liver, consistent with the identified structure. *Superior Vena Cava* - The **superior vena cava** is located in the **chest**, superior to the diaphragm, and drains blood from the upper body into the right atrium; it does not branch within the liver. - This vessel would not be visible in an abdominal CT slice at this level and does not show intrahepatic branching. *Inferior Vena Cava* - The **inferior vena cava (IVC)** is a large vessel located **posterior to the liver**, collecting deoxygenated blood from the lower body and liver (via hepatic veins) before emptying into the right atrium. - While it is in the abdomen, it does not branch within the liver parenchyma in the same manner as the portal vein; rather, **hepatic veins** drain into it from the liver. *Splenic Vein* - The **splenic vein** runs along the **posterior aspect of the pancreas** and eventually joins with the superior mesenteric vein to form the portal vein outside the liver. - It does not enter or branch within the liver itself; its location is too far posterior and outside the liver to match the structure indicated.
Question 2: A 38-year-old female presents to the physician with complaints of excessive thirst and urination for the past 4 weeks. Her appetite has been normal and she has not had diarrhea. Blood chemistry showed mildly elevated glucose and glucagon. Physical examination reveals tenderness in the left upper quadrant and an erythematous necrotizing skin eruption on her legs. Radiographic studies show a tumor in the pancreas. Which of the following cells is responsible for this lesion?
- A. Beta cell
- B. Acinar cell
- C. Delta cell
- D. Alpha cell (Correct Answer)
Explanation: ### Alpha cell - The constellation of **excessive thirst and urination (polyuria/polydipsia)**, **mildly elevated glucose**, **elevated glucagon**, **necrolytic migratory erythema (NME)**, and a **pancreatic tumor** is highly characteristic of a **glucagonoma**. [1] - Glucagonomas originate from **pancreatic alpha cells**, which are responsible for glucagon production. [2] ### Beta cell - **Beta cell tumors** (insulinomas) primarily cause **hypoglycemia** due to excessive insulin secretion, which is antithetical to the patient's symptoms of elevated glucose. [2] - While beta cell tumors can be found in the pancreas, they are not associated with necrolytic migratory erythema or glucagon excess. [1] ### Acinar cell - **Acinar cell carcinomas** are exocrine pancreatic tumors that can cause symptoms related to their size and local invasion (e.g., pain, weight loss, jaundice) but are not typically associated with specific hormonal syndromes such as glucagon excess. - They do not cause the characteristic skin rash or metabolic disturbances seen in this patient. ### Delta cell - **Delta cells** produce **somatostatin**, and tumors originating from these cells (somatostatinomas) can cause symptoms like diabetes, steatorrhea, and gallstones. - However, they do not typically present with elevated glucagon or the characteristic necrolytic migratory erythema.
Question 3: The duct of Wirsung is:
- A. Parotid duct.
- B. Common bile duct
- C. Main Pancreatic duct (Correct Answer)
- D. Accessory Pancreatic duct
Explanation: ***Main Pancreatic duct*** - The **duct of Wirsung** is the primary duct that drains **pancreatic exocrine secretions** (digestive enzymes and bicarbonate) from the pancreas into the duodenum [1]. - It typically joins the **common bile duct** to form the **ampulla of Vater**, which then empties into the second part of the duodenum [3]. *Parotid duct* - The **parotid duct** (Stensen's duct) drains secretions from the **parotid salivary gland**. - It opens into the buccal mucosa opposite the second maxillary molar tooth, not related to the pancreas. *Common bile duct* - The **common bile duct** is formed by the union of the **common hepatic duct** and the **cystic duct**, carrying bile from the liver and gallbladder [2]. - While it often merges with the main pancreatic duct before entering the duodenum, it is not the duct of Wirsung itself. *Accessory Pancreatic duct* - The **accessory pancreatic duct** (duct of Santorini) is a smaller duct that drains a portion of the head of the pancreas directly into the duodenum. - It is present in many individuals but is distinct from the main pancreatic duct (Wirsung) and often has a separate opening proximal to the ampulla of Vater.
Question 4: A 45-year-old patient with chronic pancreatitis is suffering from malnutrition and weight loss secondary to inadequate pancreatic exocrine secretions. Which of the following is true regarding pancreatic secretions?
- A. Secretin releases fluid rich in enzymes.
- B. Secretin releases fluid rich mainly in electrolytes and bicarbonate. (Correct Answer)
- C. Cholecystokinin releases fluid, predominantly rich in electrolytes, and bicarbonate.
- D. All pancreatic enzymes are secreted in an inactive form.
Explanation: ***Secretin releases fluid rich mainly in electrolytes and bicarbonate.*** - **Secretin** is stimulated by an acidic pH in the duodenum and primarily promotes the secretion of **bicarbonate-rich fluid** from the pancreas, which neutralizes gastric acid. - This bicarbonate-rich fluid helps create an optimal pH environment for digestive enzymes in the small intestine. *All pancreatic enzymes are secreted in an inactive form.* - While many pancreatic enzymes, particularly proteases like **trypsinogen** and **chymotrypsinogen**, are indeed secreted as inactive zymogens to prevent auto-digestion of the pancreas. - Some enzymes, such as **lipase** and **amylase**, are secreted in their active forms. *Secretin releases fluid rich in enzymes.* - Secretin primarily stimulates the release of **bicarbonate-rich fluid** to neutralize acidic chyme. - Enzyme rich secretions are primarily stimulated by **cholecystokinin (CCK)**. *Cholecystokinin releases fluid, predominantly rich in electrolytes, and bicarbonate.* - **Cholecystokinin (CCK)** mainly stimulates the secretion of **enzyme-rich pancreatic fluid** and contraction of the gallbladder. - The release of fluid rich in electrolytes and bicarbonate is primarily regulated by **secretin**.
Question 5: Which structure is located immediately posterior to the head of the pancreas?
- A. Portal vein (Correct Answer)
- B. Splenic artery
- C. Inferior mesenteric vein
- D. Coeliac trunk
Explanation: ***Portal vein*** - The **portal vein** is formed by the union of the **splenic vein** and the **superior mesenteric vein** (SMV) posterior to the **neck** of the pancreas [1]. - It then runs in a **groove on the posterior surface** of the head of the pancreas, lying anterior to the **inferior vena cava** (IVC). - Among the given options, the portal vein has the most direct posterior relationship to the head of the pancreas. *Splenic artery* - The **splenic artery** runs along the **superior border** of the pancreas, following its body and tail. - It does not lie posterior to the head of the pancreas. - It is a branch of the **celiac trunk** and supplies the spleen. *Inferior mesenteric vein* - The **inferior mesenteric vein** typically drains into the **splenic vein** or the junction of the splenic and superior mesenteric veins. - It ascends **anterior** to the left kidney and does not lie immediately posterior to the head of the pancreas. *Coeliac trunk* - The **celiac trunk** originates from the **abdominal aorta** at the level of T12-L1 vertebra. - It lies **superior and anterior** to the pancreas, giving off the splenic artery, common hepatic artery, and left gastric artery. - It is not located posterior to the head of the pancreas.
Question 6: Destruction of fat in acute pancreatitis is due to ?
- A. Lipase (Correct Answer)
- B. Trypsin
- C. Secretin
- D. Elastase
Explanation: ***Lipase*** - **Lipase** is the primary enzyme responsible for **fat necrosis** in acute pancreatitis. - It hydrolyzes triglycerides into **fatty acids and glycerol**. - The released fatty acids combine with calcium to form **soap (saponification)**, visible as chalky white areas of fat necrosis. - This is a characteristic pathological finding in acute pancreatitis. *Trypsin* - **Trypsin** is a proteolytic enzyme that breaks down **proteins**, not fats. - While trypsin activation is central to the pathogenesis of pancreatitis (it activates other pancreatic enzymes), **it does not directly destroy fat**. - Its primary role is in the autodigestion of pancreatic tissue and activation of the enzymatic cascade. *Secretin* - **Secretin** is a hormone that regulates pancreatic bicarbonate secretion and gastric acid secretion. - It plays **no role** in the enzymatic destruction of fat in acute pancreatitis. *Elastase* - **Elastase** is a protease that digests elastin in blood vessel walls and other proteins. - It contributes to vascular damage and hemorrhage in pancreatitis but **does not directly destroy fat**. - Fat necrosis is specifically caused by lipolytic enzymes, not proteases.
Question 7: Which of the following statements about the first part of the duodenum is false?
- A. 5 cm long
- B. Is superior part
- C. Develops from foregut
- D. Supplied by the superior mesenteric artery (Correct Answer)
Explanation: ***Supplied by the superior mesenteric artery*** - The first part of the duodenum, derived from the **foregut**, receives its blood supply from the **gastroduodenal artery**, a branch of the celiac artery [1], [2]. - The **superior mesenteric artery** primarily supplies the **midgut** derivatives, which include the distal half of the duodenum and onward [2]. *5 cm long* - The first part of the duodenum is indeed the **shortest** and widest section, typically measuring about **5 cm (2 inches)** in length. - This length allows it to course from the pylorus to the inferior border of the L1 vertebra. *Is superior part* - This statement is correct as the first part courses **superiorly** and then posteriorly, crossing the right crus of the diaphragm. - It lies at the level of the **L1 vertebra**. *Develops from foregut* - The first part of the duodenum, along with the other upper gastrointestinal structures (stomach, liver, pancreas), indeed develops from the **embryonic foregut** [1]. - The transition from foregut to midgut occurs at the level of the **major duodenal papilla**.
Question 8: What is the median survival time for patients with carcinoma of the pancreas after surgery and adjuvant therapy?
- A. Approximately 12 months
- B. Approximately 32 months
- C. Approximately 22 months (Correct Answer)
- D. Approximately 44 months
Explanation: ***Approximately 22 months*** - The median survival for patients with **resectable pancreatic adenocarcinoma** treated with surgery (typically pancreaticoduodenectomy) and adjuvant chemotherapy is approximately **22-28 months** based on contemporary studies. - The 22-month figure represents a well-established median from multiple clinical trials including **ESPAC-1 and CONKO-001**, making it the most representative answer among the options provided. - This outcome reflects significant improvement from the pre-adjuvant therapy era but still underscores the aggressive biology of pancreatic cancer. *Approximately 12 months* - This figure represents **historical median survival** prior to the routine use of effective adjuvant chemotherapy, or survival in patients with **unresectable locally advanced disease** treated with palliative chemotherapy alone. - It is **not representative** of outcomes in patients who undergo complete surgical resection followed by modern adjuvant therapy. *Approximately 32 months* - While highly selected patients with **favorable tumor biology** (small tumors, negative margins, low CA 19-9) and optimal response to modern regimens like **FOLFIRINOX** may approach this survival, it exceeds the **median survival** for the general population of resected patients. - This represents the upper quartile rather than the median outcome. *Approximately 44 months* - This exceptionally long survival is **not achieved** as a median in pancreatic ductal adenocarcinoma, even with optimal surgical resection and adjuvant therapy. - Such prolonged survival is occasionally seen in **highly selected patients** or with less aggressive pancreatic neoplasms (e.g., neuroendocrine tumors, intraductal papillary mucinous neoplasms with invasive component), which have substantially better prognoses than typical ductal adenocarcinoma.
Question 9: After pancreaticoduodenectomy (PD surgery), when should the first postoperative follow-up visit be scheduled to assess the patient's recovery?
- A. 3 weeks
- B. 4 weeks
- C. 1 week
- D. 2 weeks (Correct Answer)
Explanation: ***2 weeks*** - A 2-week recall after **pancreaticoduodenectomy (PD surgery)** allows sufficient time for early postoperative complications to manifest while still being within a window for timely intervention. - This timeframe enables assessment of **wound healing**, resolution of ileus, nutritional status, and early recognition of issues like **pancreatic fistula** or **delayed gastric emptying**. *1 week* - A 1-week recall might be too early to identify some significant complications that typically present slightly later, such as **pancreatic fistula**. - At this stage, patients are often still in the acute recovery phase, making comprehensive outpatient assessment less informative. *3 weeks* - Delaying recall until 3 weeks might be too late for optimal management of certain **postoperative complications**, potentially leading to more severe outcomes. - Early symptoms of complications could be missed, increasing the risk of re-admission or prolonged recovery. *4 weeks* - By 4 weeks, many **early complications** that require timely intervention may have become more advanced or difficult to manage. - This recall period is often used for a more routine follow-up rather than immediate assessment of acute recovery.
Question 10: In acute pancreatitis, surgery is indicated in which one of the following conditions?
- A. Infected pancreatic necrosis (Correct Answer)
- B. Acute pseudocyst
- C. Acute fluid collection
- D. Sterile pancreatic necrosis
Explanation: ***Infected pancreatic necrosis*** - **Infected pancreatic necrosis** is a severe complication of acute pancreatitis requiring surgical or percutaneous debridement (necrosectomy) to remove infected tissue and prevent sepsis. - The presence of infection in necrotic tissue significantly increases morbidity and mortality, making intervention crucial. *Acute pseudocyst* - An acute pseudocyst is usually managed conservatively and only requires intervention if it is **symptomatic**, rapidly expanding, or becomes infected. - Surgical drainage is typically reserved for large, symptomatic, or complicated pseudocysts that persist beyond 6 weeks. *Acute fluid collection* - **Acute fluid collections** are generally self-limiting and resolve without intervention. - They are typically asymptomatic and represent an early stage of fluid accumulation, often preceding pseudocyst formation. *Sterile pancreatic necrosis* - **Sterile pancreatic necrosis** is usually managed with supportive care, as surgical intervention in the absence of infection does not improve outcomes and may increase complications. - The key distinction is the absence of infection—surgery is indicated only when necrosis becomes infected.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free